Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches

References

• Aier, I., Varadwaj, P. K., & Raj, U. (2016). Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Scientific reports, 6(1) https://doi.org/10.1038/srep34984
   PubMedGoogle Scholar
• Ayoub, A. T., Elrefaiy, M. A., & Arakawa, K. (2019). Computational prediction of the mode of binding of antitumor Lankacidin C to Tubulin. ACS Omega, 4(2), 4461–4471. https://doi.org/10.1021/acsomega.8b03470
   PubMed Web of Science ®Google Scholar
• Borkotoky, S., & Murali, A. (2018). A computational assessment of pH-dependent differential interaction of T7 lysozyme with T7 RNA polymerase. BMC Structural Biology. 17, 1–11. https://doi.org/10.1186/s12900-017-0077-9
   Web of Science ®Google Scholar
• Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., … Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30(10), 1545–1614. https://doi.org/10.1002/jcc.21287
   PubMed Web of Science ®Google Scholar
• ACS. (2022). Cancer Facts & Figures. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html
   Google Scholar
• Chen, J., Zeng, Q., Wang, W., Sun, H., & Hu, G. (2022). Decoding the identification mechanism of a SAM-III riboswitch on ligands through multiple independent Gaussian-accelerated molecular dynamics simulations. Journal of Chemical Information and Modeling, 62(23), 6118–6132. https://doi.org/10.1021/acs.jcim.2c00961
   PubMedGoogle Scholar
• Chen, J., Zhang, S., Wang, W., Pang, L., Zhang, Q., & Liu, X. (2021). Mutation-induced impacts on the switch transformations of the GDP-and GTP-bound K-Ras: Insights from multiple replica gaussian accelerated molecular dynamics and free energy analysis. Journal of Chemical Information and Modeling, 61(4), 1954–1969. https://doi.org/10.1021/acs.jcim.0c01470
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7, 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Ding, P. N., Lord, S. J., Gebski, V., Links, M., Bray, V., Gralla, R. J., Yang, J., C., Lee,., & C., K. (2017). Risk of treatment-related toxicities from EGFR tyrosine kinase inhibitors: A meta-analysis of clinical trials of gefitinib, erlotinib, and afatinib in advanced EGFR-mutated non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, 12(4), 633–643.https://doi.org/10.1016/j.jtho.2016.11.2236
   PubMed Web of Science ®Google Scholar
• Fantl, W. J., Johnson, D. E., & Williams, L. T. (1993). Signalling by receptor tyrosine kinases. Annual review of Biochemistry, 62(1), 453–481. https://doi.org/10.1146/annurev.bi.62.070193.002321
   PubMedGoogle Scholar
• Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H.-J., Walker, F., Frenkel, M. J., Hoyne, P. A., Jorissen, R. N., Nice, E. C., Burgess, A. W., & Ward, C. W. (2002). Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell, 110(6), 763–773. https://doi.org/10.1016/S0092-8674(02)00940-6
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18, 1463–1472. https://doi.org/10.1021/ct5007983
   Web of Science ®Google Scholar
• Jeppe Knudsen, S. L., Wai Mac, A. S., Henriksen, L., Deurs, B. V., & Grøvdal, L. M. (2014). EGFR signaling patterns are regulated by its different ligands. Growth factors (Chur, Switzerland), 32(5), 155–163. Oct 1https://doi.org/10.3109/08977194.2014.952410
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM‐GUI: A web‐based graphical user interface for CHARMM. Journal of Computational Chemistry, 29(11), 1859–1865. https://doi.org/10.1002/jcc.20945
   PubMed Web of Science ®Google Scholar
• Kashefolgheta, S., & Verde, A. V. (2017). Developing force fields when experimental data is sparse: AMBER/GAFF-compatible parameters for inorganic and alkyl oxoanions. Physical chemistry Chemical Physics : PCCP, 19(31), 20593–20607. https://doi.org/10.1039/c7cp02557b
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Levin, W. P., Kooy, H., Loeffler, J. S., & Delaney, T. F. (2005). Proton beam therapy. British journal of Cancer, 93(8), 849–854. https://doi.org/10.1038/sj.bjc.6602754
   PubMed Web of Science ®Google Scholar
• Lindorff‐Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side‐chain torsion potentials for the Amber ff99SB protein force field. Proteins, 78(8), 1950–1958. https://doi.org/10.1002/prot.22711
   PubMed Web of Science ®Google Scholar
• Mebi, C. A. (2011). DFT study on structure, electronic properties, and reactivity of cis-isomers of [(NC 5 H 4-S) 2 Fe (CO) 2]. Journal of Chemical Sciences, 123(5), 727–731. https://doi.org/10.1007/s12039-011-0131-2
   Web of Science ®Google Scholar
• Melosky, B., & Hirsh, V. (2014). Management of common toxicities in metastatic NSCLC related to anti-lung cancer therapies with EGFR–TKIs. Frontiers in Oncology, 4, 238. https://doi.org/10.3389/fonc.2014.00238
   PubMedGoogle Scholar
• Mir, S. A., Dash, G. C., Meher, R. K., Mohanta, P. P., Chopdar, K. S., Mohapatra, P. K., Baitharu, I., Behera, A. K., Raval, M. K., & Nayak, B. (2022). In Silico and In Vitro Evaluations of Fluorophoric Thiazolo-[2, 3-b] quinazolinones as Anti-cancer Agents Targeting EGFR-TKD. Applied Biochemistry and Biotechnology, 194, 4298-4318. https://doi.org/10.1007/s12010-022-03893-w
   PubMed Web of Science ®Google Scholar
• Mir, S. A., & Nayak, B. (2022). Exploring binding stability of hydroxy-3-(4-hydroxyphenyl)-5-(4-nitrophenyl)-5, 5a, 7, 8, 9, 9a-hexahydrothiazolo [2, 3-b] quinazolin-6-one with T790M/L858R EGFR-TKD. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2022.2053748
   Web of Science ®Google Scholar
• Molsoft, L. L. C. (2007). 3366, North Torrey Pines Court, Suite 300, La Jolla, CA 92037, USA.
   Google Scholar
• Mori, Y., Kida, Y., Matsushita, Y., Mizumatsu, S., & Hatano, M. (2020). Stereotactic radiosurgery and stereotactic radiotherapy for malignant skull base tumors. Cureus, 12(6), 1-10. https://doi.org/10.7759/cureus.8401
   Web of Science ®Google Scholar
• Muhammad, A., Khunrae, P., & Sutthibutpong, T. (2020). Effects of oligolignol sizes and binding modes on a GH11 xylanase inhibition revealed by molecular modeling techniques. Journal of Molecular Modeling, 26(6), 124. https://doi.org/10.1007/s00894-020-04383-8
   PubMed Web of Science ®Google Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 1–14.
   PubMed Web of Science ®Google Scholar
• Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., & Yokoyama, S. (2002). Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell, 110(6), 775–787. https://doi.org/10.1016/S0092-8674(02)00963-7
   PubMed Web of Science ®Google Scholar
• Oliveira, M. (2015). Managing common toxicities with new tyrosine kinase inhibitors. CancerWorld, 69, 31–37.
   Google Scholar
• Parr, R. G., Szentpály, L. V., & Liu, S. (1999). Electrophilicity index. Journal of the American Chemical Society, 121(9), 1922–1924. https://doi.org/10.1021/ja983494x
   Web of Science ®Google Scholar
• Pereira, G. R. C., Da Silva, A. N. R., Do Nascimento, S. S., & De Mesquita, J. F. (2019). In silico analysis and molecular dynamics simulation of human superoxide dismutase 3 (SOD3) genetic variants. Journal of Cellular Biochemistry, 120(3), 3583–3598. https://doi.org/10.1002/jcb.27636
   PubMed Web of Science ®Google Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 9, 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   Google Scholar
• Pye, S. M., Cortes, J., Ault, P., Hatfield, A., Kantarjian, H., Pilot, R., Rosti, G., & Apperley, J. F. (2008). The effects of imatinib on pregnancy outcome. Blood, 111(12), 5505–5508. https://doi.org/10.1182/blood-2007-10-114900
   PubMed Web of Science ®Google Scholar
• Sakata, Y., Kawamura, K., Shingu, N., Hiroshige, S., Yasuda, Y., Eguchi, Y., Anan, K., Hisanaga, J., Nitawaki, T., Nakano, A., et al. ( 2020). The effects of switching EGFR-TKI treatments for non-small cell lung cancer because of adverse events. Asia-Pacific Journal of Clinical Oncology, 16(2), e113-e117. https://doi.org/10.1111/ajco.13103
   PubMed Web of Science ®Google Scholar
• Shah, R. R., & Shah, D. R. (2019). Safety and tolerability of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in oncology. Drug safety, 42(2), 181–198.https://doi.org/10.1007/s40264-018-0772-x
   PubMed Web of Science ®Google Scholar
• Shimizu, M., Adachi, S., Masuda, M., Kozawa, O., & Moriwaki, H. (2011). Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. Molecular nutrition & Food Research, 55(6), 832–843. https://doi.org/10.1002/mnfr.201000622
   PubMed Web of Science ®Google Scholar
• Shimizu, M., Shirakami, Y., & Moriwaki, H. (2008). Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG. International journal of Molecular Sciences, 9(6), 1034–1049. https://doi.org/10.3390/ijms9061034
   PubMed Web of Science ®Google Scholar
• Sousa da Silva, A. W., & Vranken, W. F. (2012). ACPYPE-Antechamber python parser interface. BMC research Notes, 5, 1–8. https://doi.org/10.1186/1756-0500-5-367
   PubMedGoogle Scholar
• Stamos, J., Sliwkowski, M. X., & Eigenbrot, C. (2002). Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. Journal of Biological Chemistry, 48, 46265–46272. https://doi.org/10.1074/jbc.M207135200
   Google Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics & Modelling, 25(2), 247–260. https://doi.org/10.1016/j.jmgm.2005.12.005
   PubMed Web of Science ®Google Scholar
• Wang, J., Youkharibache, P., Zhang, D., Lanczycki, C. J., Geer, R. C., Madej, T., Phan, L., Ward, M., Lu, S., Marchler, G. H., Wang, Y., Bryant, S. H., Geer, L. Y., & Marchler-Bauer, A. (2020). iCn3D, a web-based 3D viewer for sharing 1D/2D/3D representations of biomolecular structures. Bioinformatics (Oxford, England), 36(1), 131–135. https://doi.org/10.1093/bioinformatics/btz502
   PubMed Web of Science ®Google Scholar
• Xia, H., Dai, X., Yu, H., Zhou, S., Fan, Z., Wei, G., Tang, Q., Gong, Q., & Bi, F. (2018). EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy. Cell death & Disease, 9(3), 1–2. https://doi.org/10.1038/s41419-018-0302-x
   PubMedGoogle Scholar
• Xu, D., Li, G., Li, H., & Jia, F. (2017). Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: A systematic review and meta-analysis. Medicine, 96, 31. https://doi.org/10.1097/MD.0000000000007685
   Web of Science ®Google Scholar
• Yang, T., Wu, J. C., Yan, C., Wang, Y., Luo, R., Gonzales, M. B., Dalby, K. N., & Ren, P. (2011). Virtual screening using molecular simulations. Proteins, 79(6), 1940–1951. https://doi.org/10.1002/prot.23018
   PubMed Web of Science ®Google Scholar